← back to search

Warren E. Rose

University of Wisconsin–Madison · US
Area of research
Infectious Diseases · Pharmacology
Research interest
Research interests include Antimicrobial Resistance in Staphylococcus, Antibiotics Pharmacokinetics and Efficacy, Bacterial Identification and Susceptibility Testing, and Bacterial biofilms and quorum sensing.
h-index
41
citations
5,255
works
185
NIH funding
primary concept
email

Recent publications

Genome Mining and Metabolomics Unveil Pseudonochelin: A Siderophore Containing 5-Aminosalicylate from a Marine-Derived <i>Pseudonocardia</i> sp. Bacterium
Organic Letters 2022cited by 15position: middledoi
Current Paradigms of Combination Therapy in Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) Bacteremia: Does it Work, Which Combination, and For Which Patients?
Clinical Infectious Diseases 2021cited by 66position: firstdoi
Repurposed drugs block toxin-driven platelet clearance by the hepatic Ashwell-Morell receptor to clear <i>Staphylococcus aureus</i> bacteremia
Science Translational Medicine 2021cited by 55position: middledoi
Mortality Risk Profiling of Staphylococcus aureus Bacteremia by Multi-omic Serum Analysis Reveals Early Predictive and Pathogenic Signatures
Cell 2020cited by 121position: middledoi
Carbapenems drive the collateral resistance to ceftaroline in cystic fibrosis patients with MRSA
Communications Biology 2020cited by 17position: middledoi
Development of a vaccine against <i>Staphylococcus aureus</i> invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms
FEMS Microbiology Reviews 2019cited by 230position: middledoi
Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
Antimicrobial Agents and Chemotherapy 2019cited by 188position: middledoi
Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments
Open Forum Infectious Diseases 2019cited by 87position: lastdoi
The Role of Antibiotics in Modulating Virulence in Staphylococcus aureus
Clinical Microbiology Reviews 2017cited by 158position: middledoi
Penicillin Binding Protein 1 Is Important in the Compensatory Response of Staphylococcus aureus to Daptomycin-Induced Membrane Damage and Is a Potential Target for β-Lactam–Daptomycin Synergy
Antimicrobial Agents and Chemotherapy 2015cited by 64position: lastdoi
Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin Plus Ceftaroline
Clinical Therapeutics 2014cited by 181position: middledoi
Defining Daptomycin Resistance Prevention Exposures in Vancomycin-Resistant Enterococcus faecium and E. faecalis
Antimicrobial Agents and Chemotherapy 2014cited by 69position: middledoi
Ceftaroline Restores Daptomycin Activity against Daptomycin-Nonsusceptible Vancomycin-Resistant Enterococcus faecium
Antimicrobial Agents and Chemotherapy 2013cited by 94position: middledoi
β-Lactam Antibiotics Targeting PBP1 Selectively Enhance Daptomycin Activity against Methicillin-Resistant Staphylococcus aureus
Antimicrobial Agents and Chemotherapy 2013cited by 85position: lastdoi
Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model
Antimicrobial Agents and Chemotherapy 2012cited by 134position: middledoi
Elevated Serum Interleukin-10 at Time of Hospital Admission Is Predictive of Mortality in Patients With Staphylococcus aureus Bacteremia
The Journal of Infectious Diseases 2012cited by 114position: firstdoi
Structure and Biosynthesis of the Antibiotic Bottromycin D
Organic Letters 2012cited by 86position: middledoi
Genotypic and Phenotypic Evaluation of the Evolution of High-Level Daptomycin Nonsusceptibility in Vancomycin-Resistant Enterococcus faecium
Antimicrobial Agents and Chemotherapy 2012cited by 69position: middledoi
Altering the Proclivity towards Daptomycin Resistance in Methicillin-Resistant Staphylococcus aureus Using Combinations with Other Antibiotics
Antimicrobial Agents and Chemotherapy 2012cited by 69position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

George Sakoulas · University of California San Diego14 papers (2012–2021)Victor Nizet · CNR de la Résistance aux Antibiotiques10 papers (2012–2021)Joshua Olson · University of California San Diego5 papers (2013–2021)Michael J. Rybak · Rockefeller University4 papers (2012–2019)Poochit Nonejuie · Mahidol University4 papers (2013–2015)Joseph Pogliano · University of California San Diego4 papers (2012–2015)Andrew D. Berti · University of Saskatchewan3 papers (2012–2015) · 3 papers (2019–2021)Ryan Tewhey · Tufts University3 papers (2012–2013)Ravina Kullar · Twitter (United States)3 papers (2014–2019) · 2 papers (2012–2014)Marcus Zervos · Michigan State University2 papers (2019–2019)Tim S. Bugni · University of Wisconsin–Madison2 papers (2012–2022) · 2 papers (2019–2019) · 2 papers (2015–2019)Khulood Rizvi · The University of Texas Medical Branch at Galveston2 papers (2019–2019)Doug R. Braun · University of Wisconsin–Madison2 papers (2012–2022) · 2 papers (2019–2019)Sanjay Kumar Shukla · Edith Cowan University2 papers (2012–2019) · 2 papers (2019–2019)